{"id": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm-0", "source": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm.txt", "chunk_index": 0, "text": "Immunofixation blood test: MedlinePlus Medical Encyclopedia\n(\nLock\nthe .gov website. Share sensitive information only on official,\n→\n→\nImmunofixation blood test\nImmunofixation blood test\nThe immunofixation blood test is used to identify proteins called immunoglobulins in blood. Immunoglobulins are proteins that function as\nantibodies\n, which fight infection. There are many types of immunoglobulins that fight different types of infections. Some immunoglobulins can be abnormal and may be due to some types of\ncancer\n.\nHow the Test is Performed\nblood sample is needed\n.\nHow to Prepare for the Test\nThere is no special preparation for this test.\nHow the Test will Feel\nWhen the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or a slight bruise. This soon goes away.\nWhy the Test is Performed\nThis test is most often used to check the levels of antibodies when certain cancers and other disorders are present or suspected.\nNormal Results\nA normal (negative) result means that the blood sample had normal types and levels of immunoglobulins."}
{"id": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm-1", "source": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm.txt", "chunk_index": 1, "text": "of antibodies when certain cancers and other disorders are present or suspected.\nNormal Results\nA normal (negative) result means that the blood sample had normal types and levels of immunoglobulins. The level of one immunoglobulin was not higher than any other.\nWhat Abnormal Results Mean\nAn abnormal result may be due to:\nAmyloidosis\n(buildup of abnormal proteins in tissues and organs)\nLeukemia\n(cancer of the bone marrow)\nWaldenstrÃ¶m macroglobulinemia\n(types of lymphoma)\nLymphoma (cancer of the lymph tissue)\nMonoclonal gammopathy of unknown significance (MGUS, a type of blood disorder)\nMultiple myeloma\n(a type of blood cancer)\nOther cancers\nInfection\nRisks\nThere is little risk involved with having your blood taken. Veins and arteries vary in size from one person to another and from one side of the body to the other."}
{"id": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm-2", "source": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm.txt", "chunk_index": 2, "text": "ancer)\nOther cancers\nInfection\nRisks\nThere is little risk involved with having your blood taken. Veins and arteries vary in size from one person to another and from one side of the body to the other. Taking blood from some people may be more difficult than from others.\nOther risks associated with having blood drawn are slight, but may include:\nExcessive bleeding\nFainting\nor feeling lightheaded\nMultiple punctures to locate veins\nHematoma\n(blood accumulating under the skin)\nInfection (a slight risk any time the skin is broken)\nAlternative Names\nSerum immunofixation\nImages\nBlood test\nReferences\nGertz MA, Dispenzieri A. Amyloidosis. In: Goldman L, Cooney KA, eds.\nGoldman-Cecil Medicine\n. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 174.\nMcPherson RA. Specific proteins. In: McPherson RA, Pincus MR, eds.\nHenry's Clinical Diagnosis and Management by Laboratory Methods\n. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 20.\nRajkumar SV, Dispenzieri A. Multiple myeloma and related disorders. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds.\nAbeloff's Clinical Oncology\n. 6th ed."}
{"id": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm-3", "source": "medlineplus_encyclopedia/medlineplus.gov_ency_article_003543.htm.txt", "chunk_index": 3, "text": "evier; 2022:chap 20.\nRajkumar SV, Dispenzieri A. Multiple myeloma and related disorders. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds.\nAbeloff's Clinical Oncology\n. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 101.\nReview Date 6/17/2024\nUpdated by: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.\nRelated MedlinePlus Health Topics\nImmune System and Disorders\nLymphoma\nMultiple Myeloma"}
